Vanguard Group Discloses Significant Position in Spire Healthcare

The Vanguard Group, Inc. has released its Form 8.3, revealing its interests in Spire Healthcare Group plc. On April 1, 2026, Vanguard disclosed owning 14,531,766 ordinary shares in Spire, representing a 3.61% stake. This disclosure is in compliance with Rule 8.3 of the UK's Takeover Code, which mandates public releases when a party holds interests equivalent to 1% or more of a company's securities.

In related transactions, Vanguard purchased 78,381 shares at 1.47 GBP each while selling 4,736 shares at the same price. There were no disclosed agreements or derivative transactions impacting future securities decisions. The release confirmed no additional parties were involved in the disclosure.